ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (3): 207-213.DOI: 10.3969/j.issn.1006-298X.2023.03.002

• • 上一篇    下一篇

伴G6PD基因变异狼疮性肾炎患者的临床特点及基因变异分析

  

  • 出版日期:2023-06-28 发布日期:2023-07-01

Clinicopathological and genetic features of lupus nephritis patients with G6PD variants

  • Online:2023-06-28 Published:2023-07-01

摘要: 目的:分析3例携带葡萄糖6磷酸脱氢酶(G6PD)基因变异的狼疮性肾炎(LN)患者的临床及病理特点,讨论G6PD基因变异检测在系统性红斑狼疮(SLE)中的临床价值。
方法:收集3例患者的临床病理资料。采用全外显子测序检测LN患者的G6PD基因变异,Sanger测序检测亲属G6PD基因变异情况。G6PD/6磷酸葡萄糖脱氢酶(6PGD)比值法测定G6PD酶活性。定量聚合酶链反应(qPCR)和细胞因子微球检测技术(CBA)检测其中2例患者的炎症状态特征。
结果:3例患者均曾有血三系减低,Coombs试验均阴性,红细胞碎片均阳性,G6PD酶活性均缺乏。2例男性患者为G6PD c.G1466T(p.R489L)半合子变异,均遗传自母亲;1例女性患者为G6PD c.G1466T(p.R489L)及c.G1478A(p.R493H)复合杂合变异,分别遗传自父母双方。qPCR及CBA检测发现,与正常对照相比,2例患者血细胞干扰素刺激基因IFIT1、IFI44L、OAS1与MX2表达明显升高,血清白细胞介素8(IL-8)及γ干扰素诱导蛋白10(IP-10)明显升高,提示Ⅰ型干扰素信号通路的过度激活及炎性细胞因子的过度产生。
结论:合并G6PD基因变异的LN患者常以贫血为首发或突出临床表现,伴Ⅰ型干扰素信号通路的过度激活以及炎性细胞因子的过度产生,其在SLE发病中的作用值得进一步研究。


关键词: 葡萄糖6磷酸脱氢酶, 系统性红斑, 狼疮狼疮性, 肾炎溶血性贫血

Abstract: Objective:To summarize the clinical and pathological characteristics of 3 patients with lupus nephritis who carried the missense variants of glucose 6-phosphate dehydrogenase (G6PD) and to discuss the clinical value of G6PD variants detection in systemic lupus erythematosus.
Methodology:We collected the clinical and pathological data of 3 patients with lupus nephritis in Jinling Hospital. Pathogenic variants was screened by whole-exome sequencing (WES) in the patients and validated by Sanger sequencing in family members. G6PD/6PGD ratio method was used to test the G6PD enzyme activity. Quantitative polymerase chain reaction (qPCR) and cytometric bead array (CBA) was used to detect inflammatory signatures in two patients.
Results:All the 3 patients had a history of pancytopenia. Coombs tests were negative, but the red blood cell fragments were all positive. WES identified two kinds of variants in G6PD gene. Two males had a hemizygous variant of c.G1466T (p.R489L) inherited from their mother, while the female patient had a compound heterozygous variant of c.G1466T (p.R489L) and c.G1478A (p.R493H) inherited from the parents. The G6PD enzyme activity were all deficient. We further identified hyperactivation signatures of type I interferon signaling and overproduction of pro-inflammatory cytokines in the blood of two patients. Compared with the normal controls, the expression of in terferon-stimulated genes IFIT1, IFI44L, OAS1 and MX2 in blood cells of two patients was significantly higher, as well as the serum IL-8 and IP-10 levels.
Conclusion:Lupus nephritis patients with G6PD gene variants may present with anemia as the first or prominent clinical manifestation, accompanied by excessive activation of type I interferon signal pathway and excessive production of inflammatory cytokines in the blood. Its role in the pathogenesis of SLE deserves further study.


Key words: glucose 6-phosphate dehydrogenase variants, systemic lupus erythematosus, lupus nephritishemolytic anemia